首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

American Journal of Cardiovascular Drugs
ISSN：1175-3277

American Journal of Cardiovascular Drugs

AM J CARDIOVASC DRUG
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：>12周，或约稿
新锐分区：医学2区
年发文量：78
影响因子：3
JCR分区：Q2

基本信息

美国心血管药物杂志（American Journal of Cardiovascular Drugs）旨在促进心脏病学领域的合理治疗，涵盖心血管疾病治疗的各个方面，特别是新的和已确立的药物在治疗中的地位。通过一系列评论和原创临床研究文章，该杂志解决了与这些疾病治疗相关的主要问题，包括药理学、主要类别药物的疗效和副作用;关于新开发药物和药物类别的信息;心血管疾病病因学最新研究的治疗意义;以及具体临床情况的实际管理。《美国心血管药物杂志》提供了一系列额外的增强功能，旨在增加杂志内容的可见性、读者群和教育价值。每篇文章都附有一个要点摘要，为广大读者提供了一个省时的内容概述。文章可能附有简明的语言摘要，以帮助患者、护理人员和其他人理解重要的医学进展。该杂志还提供了包括各种其他类型的增强功能的选项，包括幻灯片集、视频和动画。所有增强功能都经过同行评审，达到与文章本身相同的高标准。同行评审使用Editorial Manager®进行，并由国际专家数据库提供支持。此数据库与其他Adis期刊共享。
1175-3277SCIE/Scopus收录
3
点击查看最新影响趋势>
3.1
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学2区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区
PHARMACOLOGY & PHARMACY 药学
2区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
Q2
76/231
学科：PHARMACOLOGY & PHARMACY
SCIE
Q2
138/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
Q2
89/231
学科：PHARMACOLOGY & PHARMACY
SCIE
Q2
171/353
46
78
点击查看年发文量趋势图>
12%0>12周，或约稿-医学-心血管系统
3.3%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
39.74%27.75%-
CiteScore：5.40
SJR：0.876
SNIP：0.828
学科类别分区排名百分位
大类：Medicine
小类：Cardiology and Cardiovascular Medicine
Q2
107 / 397
大类：Medicine
小类：Pharmacology (medical)
Q2
88 / 275

期刊高被引文献

Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-018-00320-6
Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation Across BMI Categories: A Systematic Review and Meta-Analysis
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00362-4
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00339-3
Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00341-9
Cardiovascular Protection with Anti-hyperglycemic Agents
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00325-9
Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00369-x
Pharmacotherapy of Obesity: Limits and Perspectives
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00328-6
The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00348-2
Evidence-Based Cardiovascular Risk Management in Diabetes
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00336-6
Effect of Spironolactone on Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: Post-Hoc Analysis of the Randomized, Placebo-Controlled TOPCAT Trial
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00353-5
Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00361-5
Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00381-1
Efficacy and Safety of Ticagrelor Compared with Clopidogrel in Patients with End-Stage Renal Disease with Acute Myocardial Infarction
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-018-00318-0
Postoperative Atrial Fibrillation Following Cardiac Surgery: From Pathogenesis to Potential Therapies
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00365-1
Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00367-z
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00373-1
Effect of Warfarin on Ischemic Stroke, Bleeding, and Mortality in Patients with Atrial Fibrillation Receiving Peritoneal Dialysis
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00347-3
Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00382-0
Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-018-00316-2
Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant Drugs
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00374-0
Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00326-8
Assessment and Management of Patients with Hyperlipidemia Referred for Initiation of PCSK9 Inhibitor Therapy: A Lipid Clinic Experience
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00352-6
Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00371-3
Impact of Perioperative Levosimendan Administration on Risk of Bleeding After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00372-2
Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00377-x
Renin–Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort Study
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00343-7
Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-018-00317-1
Predictors of Left Ventricular Dysfunction in Friedreich’s Ataxia in a 16-Year Observational Study
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00375-z
Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00383-z
Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-018-00319-z
Ubiquinol Improves Endothelial Function in Patients with Heart Failure with Reduced Ejection Fraction: A Single-Center, Randomized Double-Blind Placebo-Controlled Crossover Pilot Study
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00384-y
Non-inferiority Trial Design in Drug Development: A Primer for Cardiovascular Healthcare Professionals
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00378-w
Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00338-4
Effects of Rosuvastatin and Aspirin on Retinal Vascular Structures in Hypercholesterolemic Patients with Low-to-Moderate Risk of Coronary Artery Disease
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00330-y
Current Evidence for Pharmacologic Reversal Using Direct Oral Anticoagulants: What’s New?
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00366-0
Plasma Metabolites as Predictors of Warfarin Outcome in Atrial Fibrillation
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00364-2
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00351-7
Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00379-9
A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00349-1
Correction to: Plasma Vitamin K1 Levels in Italian Patients Receiving Oral Anticoagulant Therapy for Mechanical Heart Prosthesis: A Case–Control Study
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00331-x
Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00391-z
Comparison of Venous Thromboembolism Prophylactic Measures Post Coronary Artery Bypass Graft Surgery
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00354-4
Authors’ Reply to Rana et al. “Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials”
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00334-8
Effects of Statins to Reduce All-Cause Mortality in Heart Failure Patients: Findings from the EPICAL2 Cohort Study
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00346-4
Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet Therapy?
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00340-w
Overall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular Disease
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00376-y
Dexmedetomidine Reduces Atrial Fibrillation After Adult Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00380-2
Renin–Angiotensin–Aldosterone System Optimization for Acute Decompensated Heart Failure Patients (ROAD-HF): Rationale and Design
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00389-7
Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00335-7
Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation and Hypertension: A Meta-Analysis
来源期刊：American Journal of Cardiovascular DrugsDOI：10.1007/s40256-019-00342-8

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACADEMIC EMERGENCY MEDICINE封面

ACADEMIC EMERGENCY MEDICINE

学科领域：医学
影响因子：3.2
中科院分区： 2区
ACADEMIC RADIOLOGY封面

ACADEMIC RADIOLOGY

学科领域：医学
影响因子：3.9
中科院分区： 2区
APPETITE封面

APPETITE

学科领域：医学
影响因子：3.8
中科院分区： 2区
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA封面

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

学科领域：医学
影响因子：3.1
中科院分区： 2区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布
大类学科小类学科Top期刊综述期刊
医学2区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区
PHARMACOLOGY & PHARMACY 药学
2区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
否